🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 10806X102
- Market Cap
- Large Cap · $8 Billion
- IPO
- 6/27/2019 · $17.00/share
Business: BridgeBio Pharma, Inc. finds, develops, and delivers breakthrough medicines for genetic diseases. The company bridges remarkable advancements in genetic science with the entrepreneurial engine required to rapidly create lifesaving medicines for patients with unmet needs. Founded in 2015 by a team of industry veterans, the company has built a portfolio of more than 15 transformative drugs ranging from pre-clinical to late stage development in multiple therapeutic areas including genetic dermatology, oncology, cardiology, neurology, endocrinology, renal disease, and ophthalmology.
Company Contact
- CEO
- Neil Kumar
- CFO
- Brian C. Stephenson
- Headquarters
- 421 Kipling Street, Palo Alto, CA 94301
- Phone
- 650-391-9740
- Investor Relations
- Alberto Gestri, The Outcast Agency · 650-391-9740 · AGestri@theoutcastagency.com